Evidence map›Paper›PMID 18039372›Full record

ArticleBMC genomics2007

The TriTryp phosphatome: analysis of the protein phosphatase catalytic domains.

Rachel Brenchley, Humera Tariq, Helen McElhinney, Balázs Szöor, Julie Huxley-Jones, Robert Stevens, Keith Matthews, Lydia Tabernero

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Protein Serine/Threonine Phosphatase Type 2C ofFrontiers in cellular and infection microbiology · 2021
    Article
  11. Protein Phosphatase PP2C Identification inBioMed research international · 2021
    Article
  12. TheFrontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Journal of immunology research · 2020
    Article
  15. Article
  16. Identification of Functional and Druggable Sites inInternational journal of molecular sciences · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rachel BrenchleyFaculty of Life Sciences, Michael Smith, University of Manchester, M13 9PT, UK. Rachel.Brenchley@postgrad.manchester.ac.uk
Humera Tariq
Helen McElhinney
Balázs Szöor
Julie Huxley-Jones
Robert Stevens
Keith Matthews
Lydia Tabernero
University of Manchester · GBUniversity of Edinburgh · GBGlaxoSmithKline (United Kingdom) · GB

Funding

Wellcome Trust 068793Wellcome Trust 073358Wellcome Trust 082555
6 · The paper itself

Abstract

backgroundThe genomes of the three parasitic protozoa Trypanosoma cruzi, Trypanosoma brucei and Leishmania major are the main subject of this study. These parasites are responsible for devastating human diseases known as Chagas disease, African sleeping sickness and cutaneous Leishmaniasis, respectively, that affect millions of people in the developing world. The prevalence of these neglected diseases results from a combination of poverty, inadequate prevention and difficult treatment. Protein phosphorylation is an important mechanism of controlling the development of these kinetoplastids. With the aim to further our knowledge of the biology of these organisms we present a characterisation of the phosphatase complement (phosphatome) of the three parasites.

resultsAn ontology-based scan of the three genomes was used to identify 86 phosphatase catalytic domains in T. cruzi, 78 in T. brucei, and 88 in L. major. We found interesting differences with other eukaryotic genomes, such as the low proportion of tyrosine phosphatases and the expansion of the serine/threonine phosphatase family. Additionally, a large number of atypical protein phosphatases were identified in these species, representing more than one third of the total phosphatase complement. Most of the atypical phosphatases belong to the dual-specificity phosphatase (DSP) family and show considerable divergence from classic DSPs in both the domain organisation and sequence features.

conclusionThe analysis of the phosphatome of the three kinetoplastids indicates that they possess orthologues to many of the phosphatases reported in other eukaryotes, including humans. However, novel domain architectures and unusual combinations of accessory domains, suggest distinct functional roles for several of the kinetoplastid phosphatases, which await further experimental exploration. These distinct traits may be exploited in the selection of suitable new targets for drug development to prevent transmission and spread of the diseases, taking advantage of the already extensive knowledge on protein phosphatase inhibitors.

Indexed as

AnimalsCatalytic DomainLeishmania majorPhosphoprotein PhosphatasesPhylogenySubstrate SpecificityTrypanosoma brucei bruceiTrypanosoma cruziPhosphoprotein Phosphatases

Identifiers

PMID18039372
PMCPMC2175518
OpenAlexW2150238266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.